|
시장보고서
상품코드
2091619
폴립 생검 시장 규모, 점유율 및 성장 분석 : 제품별, 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Polyp Biopsy Market Size, Share, and Growth Analysis, By Product (Instruments, Kits and Consumables), By Type (Forceps Biopsy, Snare Biopsy), By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 폴립 생검 시장 규모는 2024년에 259억 달러로 평가되며, 2025년 279억 2,000만 달러에서 2033년까지 609억 2,000만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 7.81%로 성장할 것으로 전망되고 있습니다.
전 세계 용종 생검 시장은 소화관 용종의 적출 및 분석에 필수적인 장비와 서비스를 중심으로 구성되어 있으며, 주요 지역의 대장암 발병률 증가와 선별 검사 프로그램 확대에 따라 암의 조기 발견에 매우 중요한 역할을 하고 있습니다. 내시경 점막하층 박리 키트(ESD 키트)의 도입으로 기존 방법이 발전하여 조직 채취의 정확도가 향상되고 병변의 누락이 감소함에 따라 병원에서는 내시경 장비의 업그레이드가 진행되고 있습니다. 시장 성장을 이끄는 주요 촉진요인 중 하나는 내시경 영상 진단에 인공지능(AI)을 접목하는 것으로, 이를 통해 용종 탐지 정확도가 향상되고 표적 생검이 가능해집니다. AI를 통한 의심 병변의 실시간 식별을 통해 영상 유도 하에 적시에 조직을 채취할 수 있게 되어 진단 정확도가 향상됩니다. AI를 활용한 시술의 도입은 업무 효율 향상에 기여하며, 보험사의 보험 적용에 대한 신뢰를 높이고, 나아가 시장 확대를 지원하고 있습니다.
전 세계 용종 생검 시장의 성장 요인
내시경 시스템에 인공지능을 도입하면, 실시간 용종 탐지 정확도를 대폭 향상시키고, 생검과 관련된 의사결정 과정을 간소화합니다. 이러한 발전 덕분에 임상의들은 보다 철저한 생검을 실시하도록 장려될 뿐만 아니라, 시술 과정의 불확실성이 최소화되고 신규 사용자의 숙련 기간도 단축되므로, 진단에 유용한 조직을 확실하게 채취할 수 있다는 자신감이 높아집니다. 그 결과, 의료기관과 외래 진료 시설은 AI를 활용한 플랫폼에 대한 투자에 점점 더 적극적인 태도를 보이고 있습니다. 이러한 추세는 다양한 의료 현장에서 각종 생검 기기 및 소모품에 대한 수요 확대를 이끄는 주요 요인이 되고 있으며, 환자의 치료 성과 향상에 기여하고 있습니다.
세계 용종 생검 시장의 제약 요인
전 세계 용종 생검 시장은 규제 당국의 승인 지연으로 인해 새로운 생검 기기의 도입 일정이 장기화되는 중대한 과제에 직면해 있습니다. 이러한 심사 절차의 장기화에 따라 안전성 및 유효성에 관한 포괄적인 문서화가 요구되고 있으며, 그 결과 제품의 적시 출시가 지장을 받고 있습니다. 의료 서비스 제공자들은 제품이 필요한 규제 당국의 승인을 받을 때까지 구매 결정을 미루는 경우가 많아, 당장의 수요에 부정적인 영향을 미치고 있습니다. 이러한 예측 불가능성으로 인해 제조업체의 매출 예측이 더욱 어려워져, 시장 전체의 성장을 저해할 가능성이 있습니다. 또한 승인에 관한 불확실성은 중소기업의 틈새 기술에 대한 투자 의지를 저해할 가능성이 있으며, 그 결과 시장 내의 다양성과 혁신이 제한될 수 있습니다.
전 세계 용종 생검 시장의 동향
전 세계 용종 생검 시장에서는 저침습 기술 도입을 향한 뚜렷한 추세가 나타나고 있으며, 영상 진단 능력을 향상시키는 첨단 내시경 시스템에 대한 관심이 높아지고 있습니다. 이러한 변화로 인해 환자의 편안함과 효율적인 조직 채취를 우선시하는 용종 생검 기구에 대한 수요가 증가하고 있습니다. 각 제조사들은 더 작고 사용하기 편리한 집게와 스네어를 설계함으로써 혁신을 추진하고 있으며, 이를 통해 시술 시간을 단축하고 외래 진료를 활성화할 수 있게 되었습니다. 이러한 발전은 입원 기간 및 비용 절감을 목표로 할 뿐만 아니라, 생산성 향상과 환자 예후 최적화라는 의료 분야의 포괄적인 목표와도 부합하며, 궁극적으로는 용종 진단 방식을 혁신하는 결과로 이어질 것입니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 폴립 생검 시장 규모 : 제품별
세계의 폴립 생검 시장 규모 : 유형별
세계의 폴립 생검 시장 규모 : 용도별
세계의 폴립 생검 시장 규모 : 최종사용자별
세계의 폴립 생검 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.07.21Global Polyp Biopsy Market size was valued at USD 25.9 Billion in 2024 and is poised to grow from USD 27.92 Billion in 2025 to USD 60.92 Billion by 2033, growing at a CAGR of 7.81% during the forecast period (2026-2033).
The global polyp biopsy market is centered around devices and services integral to the extraction and analysis of gastrointestinal polyps, crucial for early cancer detection amidst rising colorectal cancer rates and expanding screening programs in key regions. Traditional methods have evolved with the introduction of endoscopic submucosal dissection kits, facilitating enhanced tissue sampling and reducing missed lesions, prompting hospitals to upgrade their endoscopy facilities. A significant driver of market growth is the integration of artificial intelligence in endoscopic imaging, which boosts polyp detection and guides targeted biopsies. Real-time AI identification of suspicious lesions allows for timely, image-guided sampling, improving diagnostic yield. Adoption of AI-enhanced procedures has led to better operational efficiency, increasing confidence in reimbursement coverage from insurance companies, thus fueling market expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Polyp Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Polyp Biopsy Market Segments Analysis
Global polyp biopsy market is segmented by product, type, application, end user and region. Based on product, the market is segmented into instruments, kits and consumables and services. Based on type, the market is segmented into forceps biopsy, snare biopsy and brush biopsy. Based on application, the market is segmented into colorectal polyps, gastric polyps and nasal polyps. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Polyp Biopsy Market
The incorporation of artificial intelligence into endoscopic systems significantly boosts the accuracy of real-time polyp detection and simplifies the decision-making process for biopsies. This advancement not only encourages clinicians to implement more thorough sampling practices but also minimizes procedural uncertainties and shortens the learning curve for new users, thereby enhancing their confidence in acquiring diagnostically pertinent tissue. As a result, healthcare institutions and outpatient facilities are increasingly motivated to invest in AI-powered platforms. This trend is a key driver for the growing demand for various biopsy equipment and consumables across diverse healthcare settings, facilitating improved patient outcomes.
Restraints in the Global Polyp Biopsy Market
The Global Polyp Biopsy market faces significant challenges due to delays in regulatory approvals, which extend the timelines for introducing new biopsy devices. These prolonged review processes necessitate comprehensive documentation related to safety and efficacy, subsequently hindering timely product launches. As healthcare providers often postpone purchasing decisions until products receive necessary regulatory endorsements, immediate demand is negatively impacted. This unpredictability makes revenue forecasting for manufacturers more challenging, potentially stifling overall market expansion. Furthermore, the uncertainty surrounding approvals can deter smaller companies from investing in niche technologies, thereby limiting the diversity and innovation within the market.
Market Trends of the Global Polyp Biopsy Market
The global polyp biopsy market is witnessing a significant trend towards the adoption of minimally invasive technologies, with an increasing emphasis on advanced endoscopic systems that enhance imaging and diagnostic capabilities. This shift is fostering heightened demand for polyp biopsy instruments that prioritize patient comfort and efficient tissue collection. Manufacturers are innovating by designing smaller, more user-friendly forceps and snares, enabling quicker procedures and promoting outpatient care. Such advancements not only aim to reduce hospitalization times and costs but also align with the healthcare sector's overarching goals of enhancing productivity and optimizing patient outcomes, ultimately reshaping the landscape of polyp diagnostics.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Polyp Biopsy Market Size by Product & CAGR (2026-2033)
- Market Overview
- Instruments
- Kits and Consumables
- Services
Global Polyp Biopsy Market Size by Type & CAGR (2026-2033)
- Market Overview
- Forceps Biopsy
- Snare Biopsy
- Brush Biopsy
Global Polyp Biopsy Market Size by Application & CAGR (2026-2033)
- Market Overview
- Colorectal Polyps
- Gastric Polyps
- Nasal Polyps
Global Polyp Biopsy Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
Global Polyp Biopsy Market Size & CAGR (2026-2033)
- North America (Product, Type, Application, End User)
- US
- Canada
- Europe (Product, Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Type, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- STAAR Surgical Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inari Medical Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Steris plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ConMed Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microtech Endoscopy USA Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- US Endoscopy Group Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shockwave Medical Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Karl Storz SE and Co
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Erbe Elektromedizin GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Establishment Labs Holdings Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merit Medical Systems Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cutera Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CC Diagnostics Pvt Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Apollo Endosurgery Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wilson Cook Medical Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
